🤖 Cerenome Reports Second Quarter 2026 Financial Results
Published by OOPSONLINE.IN · Source: The Manila Times · 1 min read · · Updated
What actually happened
HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ('Cerenome' or the 'Company'), a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence, today announced financial results for the second quarter ended June 30, 2026, and provided an overview of recent and upcoming business highlights.
Key points
- 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc.
- (Nasdaq: CNSY) ('Cerenome' or the 'Company'), a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence, today announced financial results for the second quarter ended June 30, 2026, and provided an overview of recent and upcoming business highlights.
Summary based on data provided by The Manila Times. Full article available at the original publisher.
- #ai
- #cerenome
- #reports